Smarter insights, faster decisions, real impact

HelixAI transforms the way pharma teams access, analyze, and act on intelligence, driving better decision-making across medical, market access, and clinical functions.
Learn more
Arrange custom demo
Header imageArrowArrow
Upload UI elementUpload UI element
Upload UI element
Upload UI elementUpload UI element
HelixAI
Use case

Medical Affairs

Data-driven scientific engagement

Medical strategy

Use real-time insights to align scientific communications with emerging trends and evidence in your therapy area.

Stakeholder engagement

Identify and track KOLs, DOLs, and rising experts to optimize scientific exchange and engagement strategies.

Field medical impact

Capture, structure, and analyze MSL-gathered insights in real time, linking them to the latest evidence, publications, and strategic priorities.

Publication planning

AI-powered summarization and conversational AI distill dense publications into clear takeaways, all grounded in your knowledge base for compliance and accuracy.
Explore HelixAI
Arrange custom demo
Dashboard mockup
Dashboard mockup
HelixAI
Use case

Market Access

Smarter access and pricing strategies

Access strategy

Leverage HTA submissions, competitor insights, and reimbursement trends to refine strategic market access plans with AI-driven intelligence.

Early access decisions

Analyze emerging clinical and real-world evidence to support pricing, reimbursement, and access decisions before full market approval.

Value demonstration

Use AI-powered publication monitoring insights to strengthen payer negotiations and optimize value communication.

Stakeholder engagement

Identify and track Market Access KOLs and advocacy groups, ensuring engagement strategies are backed by real-time, evidence-based insights.
Explore HelixAI
Arrange custom demo
HelixAI
Use case

Clinical Development

Optimized trial strategies

Trial design optimization

Leverage real-world evidence, competitor trial data, and clinical guidelines to design smarter, more effective studies.

Site and investigator selection

Identify top-performing trial sites, key investigators, and emerging experts based on publication activity and trial success rates.

Competitive intelligence

Track competitor trial designs, outcomes, and study endpoints to refine strategy and stay ahead in development.

Strategic evidence generation

Monitor scientific publications, real-world data, and emerging research to strengthen your clinical and commercial evidence base.
Explore HelixAI
Arrange custom demo
Dashboard mockup
Dashboard mockup
HelixAI
Use case

Cross-Functional Teams

A single source of truth

Centralized intelligence hub

Every function works with the same high-quality insights, no starting from scratch, no silos, no outdated data.

AI-powered efficiency

AI-powered summarization and conversational AI make it easy to extract relevant insights for any team, at any time.

Faster, evidence-based decision making

Eliminate time wasted searching for critical intelligence, HelixAI organizes, visualizes, and alerts you to what matters most.

Secure, role-based access

Each team member sees only the intelligence relevant to their role, enabling seamless collaboration while maintaining data security and compliance.
Explore HelixAI
Arrange custom demo
Testimonals

What our clients say about us

"This is allowing me to answer questions I didn’t even know I had"
Medical Affairs Director
"I haven't seen anything like it with any other consulting group, ever."
VP Market Access & Reimbursement
"Thank you VISFO, this is incredible value for money"
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs"
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible"
Senior Director
This is allowing me to answer questions I didn’t even know I had!”
Medical Affairs Director
"Thank you VISFO, this is incredible value for money."
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs."
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible."
Senior Director